Pharvaris (PHVS) Shares Outstanding (Weighted Average) (2019 - 2026)

Pharvaris (PHVS) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $9.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed N/A year-over-year to $9.2 million; the trailing twelve-month figure through Mar 2026 stood at $9.2 million (changed N/A YoY), and the FY2025 full-year result was $8.8 million, up 25.67% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $9.2 million, up from $9.1 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $9.2 million in Q1 2026 and bottomed at $4.2 million in Q4 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $6.9 million (2024), against an average of $7.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) fell 8.59%; it then jumped 62.05% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $4.2 million in 2022, then surged by 62.05% to $6.8 million in 2023, then climbed by 2.47% to $6.9 million in 2024, then jumped by 31.14% to $9.1 million in 2025, then gained by 0.9% to $9.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $9.2 million (Q1 2026), $9.1 million (Q4 2025), and $6.9 million (Q4 2024), per Business Quant data.

Peer Comparison